BioPharma companies and Medical Device manufacturers face growing operational, regulatory and economic challenges. ICON provides analysis and key insights on these challenges, with practical advice and recommendations.
加速和改善临床试验的技术。
Patients are now better informed on clinical options than they ever have been.
Regulatory experts partnering with you.
Thought leadership from ICON's global team of therapeutic experts.
传统的临床发展模式需要改变。
传统的医疗保健交付模式正在发生变化。
强大的风险分析和评估审查应决定监测策略,需要对所有研究进行。
The promise and complexity of living therapies.
From antiretroviral therapy to vaccines, where we are today and what’s next.
图标第三次年度调查结果。
达到2022年截止日期的路线图,同时导航大流行中断。
了解贝叶斯和频繁的方法。
Current views and future outlook.
The flexibility to keep your trials on track.
从识别生物标志物以提高临床试验效率。
正规患者参与稀有疾病毒药发展的分析。
在全球大流行期间确保患者的安全和审判诚信。
Exploring the patient dynamic from different perspectives.
An end-to-end approach to managing wearable devices through clinical development.
了解有关估价值的更多信息以及部署此方法将如何提高临床研究质量。
最大限度地提高HTA成功的见解。
The patient perspective.
在世界等待时加速业务的最佳实践。
图标通过其全球网站网络进行了调查,以获得患者视图。
深入的访谈揭示了美国付款人所需的制造商。
为什么外包药物知识在联盟级别进行了意义
Discover how emerging technologies can increase clinical trial efficiency
利用数字技术的力量。
来自高级制药高管的透视
Engage assay experts with unparalleled experience and expertise
Understanding the challenges for formulary decision makers and manufacturer
Determine the right design, assessments and endpoints in your pain study
开发合适的业务策略以成功导航MDR / IVDR
primary research evaluating ICER’s influence over payers and manufactures
通过自动化提高效率
开发一个综合的患者为中心的方法来利用数字健康技术
Get the insights you need for successful biosimilar commercialisation
全球调查员付款解决方案
ICON’s monthly Regulatory Intelligence Newsletter
Legacy Data Conversion
Remote monitoring and leveraging wearable devices and sensors in clinical trials.
An adaptive design clinical trial can help to create a stronger value proposition for your medical device by reducing development costs and accelerating time-to-market.